Skip to Content
Home
|
Sitemap
|
Contact BRP
Search this site
Home
About BRP
Staff Directory
Biostatistics Branch
Computational & Systems Biology Branch
BRP Alumni
Position Available
Research Area
Clinical Trials
Drug Discovery and Pre-Clinical Development
Molecular Cancer Diagnosis
Biomedical Imaging
Computational and Systems Biology
Biostatistical Research
Online Sample Size Calculation
Predictive Biomarkers in Phase II/III Clinical Trials
Optimal Two-Stage Designs for Phase II Clinical Trials
Integrated Phase II/III Study
Sample Size Planning for Developing Classifiers
Design, Monitoring and Analysis of Bayesian Basket Discovery Trials
Bayesian Phase II Single Arm Clinical Trials
Software Download
Accelerated Titration Design Software
BRB-ArrayTools
BRB-SeqTools
TPWshiny
D3Oncoprint
OpenGeneMed
Optimal Two-Stage Phase II Design Software
pCR Trial-Level Surrogate Analysis Software
MutSpliceDB
tmbLab
Publications and Reports
Reprints
Workshop Presentations
Predictive Biomarkers in Phase II/III Clinical Trials
Biomarker Targeted Randomized Design
Biomarker Stratified Randomized Design
Binary Endpoint
Time-to-Event Endpoint
Optimal Two-Stage Designs For Phase II Clinical Trials
Integrated Phase II/III Study
Sample Size Planning for Developing Classifiers Using High Dimensional Data
Design, Monitoring and Analysis of Bayesian Basket Discovery Trials
Bayesian Phase II Single Arm Clinical Trials
Online Sample Size Calculation
Last Updated:
Predictive Biomarkers in Phase II/III Clinical Trials
Biomarker Stratified Randomized Design
Stratified design randomizes both marker positive and negative patients.
Richard Simon, Clinical Cancer Research 14:5984-93, 2008.
Richard Simon, Expert Opinion in Medical Diagnostics, 2:721-29, 2008.
Richard Simon, Developing Molecular Diagnostics for Cancer (Winther & Jorgensen eds).
Stratified Design with Prospective Analysis Plan and Binary Endpoint
Stratified Design with Prospective Analysis Plan and Time-to-Event Endpoint
